10-Q: AFCG Reports Q3 Loss, Shifts to BDC Model, Expands Lending

Advanced Flower Capital Inc. reported a net loss for Q3 2025, driven by increased credit loss provisions and unrealized losses, while progressing its conversion to a Business Development Company and expanding its investment strategy beyond cannabis.

Summary

• A net loss from continuing operations of $(12.5) million, or $(0.57) per basic common share, was reported for Q3 2025, compared to net income of $1.2 million, or $0.05 per share, in Q3 2024.
• For the nine months ended September 30, 2025, the net loss from continuing operations was $(21.6) million, or $(0.99) per basic common share, a significant decline from net income of $14.9 million, or $0.71 per share, in the same period of 2024.
• Interest income decreased by $(2.3) million (21.9%) for Q3 2025 and $(18.1) million (42.3%) for the nine months ended September 30, 2025, primarily due to loans on nonaccrual status and lower fee/OID income from prior period loan exits and prepayments.
• The provision for current expected credit losses increased substantially by $7.2 million for Q3 2025 and $23.7 million for the nine months ended September 30, 2025, reflecting increased reserves for higher-risk loans.
• Unrealized losses on loans at fair value increased by $(9.7) million for Q3 2025 and $(11.5) million for the nine months ended September 30, 2025, impacted by changes in recovery rates.
• The company is converting from a REIT to a Business Development Company (BDC), with shareholders approving the Investment Advisory Agreement on November 6, 2025.
• The investment strategy has expanded to include companies ancillary to the cannabis industry and companies outside of the cannabis industry.
• Book value per share decreased to $7.49 as of September 30, 2025, from $9.02 as of December 31, 2024.
• Dividends declared for the nine months ended September 30, 2025, totaled $0.53 per share ($11.98 million total), down from $1.44 per share ($30.16 million total) in the same period of 2024.
• No dividend is anticipated for Q4 2025 due to an expected $4.1 million taxable loss from a settlement agreement.
• The Revolving Credit Facility's maturity date was extended to April 29, 2028, and its commitment increased to $50.0 million.
• A legal complaint was filed against the company, its manager, and officers/directors in California, alleging breach of fiduciary duty, conversion, intentional interference with contract, and unjust enrichment, seeking substantial monetary damages. The company believes the claims are baseless.

Sentiment

Score: 3

Explanation: The company reported substantial net losses, significant increases in credit loss provisions and unrealized losses, and a notable decline in interest income and book value per share. The suspension of the Q4 dividend further highlights financial strain. While the BDC conversion and expanded investment strategy offer long-term potential for diversification, the immediate financial results and ongoing legal proceedings present considerable challenges and uncertainty.

Positives

• Shareholders approved the Investment Advisory Agreement on November 6, 2025, a key step in the BDC conversion, which is expected to broaden investment opportunities and enhance portfolio diversification.
• The investment strategy expanded to include companies ancillary to and outside of the cannabis industry, aiming for diversification and attractive risk-adjusted returns.
• The Revolving Credit Facility maturity date was extended to April 29, 2028, and its commitment increased to $50.0 million, enhancing liquidity.
• A settlement agreement was reached with Private Company P for $13.3 million, resolving claims related to a non-performing loan, with $6.0 million financed by a new loan to Private Company T, indicating active management of distressed assets.
• Approximately $4.2 million in loan payments were received from Private Company A's collateral asset sale in October 2025, reducing the outstanding principal balance.

Negatives

• A net loss from continuing operations of $(12.5) million for Q3 2025 and $(21.6) million for the nine months ended September 30, 2025, represents a significant decline from net income in the prior year periods.
• Basic EPS from continuing operations was $(0.57) for Q3 2025 and $(0.99) for the nine months ended September 30, 2025, compared to positive EPS in the prior year.
• Interest income decreased significantly by $(2.3) million (21.9%) for Q3 2025 and $(18.1) million (42.3%) for the nine months ended September 30, 2025.
• The provision for current expected credit losses increased substantially by $7.2 million for Q3 2025 and $23.7 million for the nine months ended September 30, 2025, indicating deteriorating credit quality in the loan portfolio.
• Unrealized losses on loans at fair value increased by $(9.7) million for Q3 2025 and $(11.5) million for the nine months ended September 30, 2025.
• Book value per share decreased from $9.02 at December 31, 2024, to $7.49 at September 30, 2025.
• Dividends declared per share significantly decreased from $1.44 for the nine months ended September 30, 2024, to $0.53 for the same period in 2025, and no dividend is anticipated for Q4 2025.
• Four loans are on nonaccrual status as of September 30, 2025, with a combined carrying value of $104.2 million (net of CECL Reserve $59.9 million), and one loan held at fair value with an outstanding principal of $51.0 million (fair value $16.9 million).
• Legal proceedings have been initiated against the company, its manager, and officers/directors alleging serious claims and seeking substantial monetary damages.

Risks

• Strict enforcement against borrowers due to the federal illegality of cannabis could occur, impacting the company's cannabis industry loans.
• Borrowers' inability to renew or maintain licenses for cannabis operations poses a significant risk.
• Loans to cannabis industry operators lack liquidity, and the company could lose all or part of any loans.
• New laws adverse to borrowers or changes in favorable state/national laws regarding cannabis could impede growth and materially affect the business.
• If a loan defaults or collateral is seized, the company may be prohibited from owning cannabis assets, forcing a sale of the loan at a potential loss.
• There is no assurance that the Board will approve all matters required to effect the BDC Conversion, despite shareholder approval of the Investment Advisory Agreement.
• The loan portfolio is concentrated, with the top three borrowers representing approximately 49.5% of aggregate outstanding principal balances as of September 30, 2025, and the largest credit facility (Subsidiary of Private Company G) representing 23.7% of outstanding principal and being on nonaccrual status.
• Unanticipated credit losses could occur, adversely impacting operating results, despite mitigation efforts.
• Exposure to interest rate fluctuations, where borrowing costs may increase faster than yields on floating-rate assets, or fixed-rate assets remain static, potentially decreasing net interest spread and net income.
• Floating-rate assets may have interest rate caps, while borrowing costs may not, leading to a mismatch in rising interest rate environments and potentially deferred interest.
• Due to the illiquid nature of loans, fair value determinations are inherently uncertain and may fluctuate significantly, potentially differing from ultimately realized values.
• The company is subject to legal proceedings that could result in substantial monetary damages and negatively impact its business, financial condition, or results of operations.
• No assurances can be given that the company will continue to qualify as a REIT, which depends on satisfying numerous asset, income, and distribution tests.
• The company's ability to locate suitable loan opportunities, monitor the portfolio, and implement investment strategy depends on its Manager.
• Changes in general economic conditions, the industry, and commercial finance/real estate markets can impact results.
• Industry consolidation among cannabis operators could increase concentration of the borrower portfolio.

Future Outlook

The company intends to convert from a REIT to a Business Development Company (BDC), which, if approved by the Board, will allow it to invest in a much broader universe of assets, including both real estate and non-real estate related assets, and expand its ability to lend to ancillary cannabis businesses and non-real estate covered vertically integrated operators. This expanded mandate is expected to enhance portfolio diversification, increase investment flexibility, and support the pursuit of attractive risk-adjusted returns. The company expects to raise further equity capital and issue debt securities to fund future investments in line with its expanded focus. Due to an expected taxable loss from a settlement, the company does not anticipate paying a dividend for the fourth quarter of 2025.

Management Comments

• "We believe we continue to be well positioned to act as a prudent financing source to cannabis industry operators given our stringent underwriting criteria, size and scale of operations and institutional infrastructure."
• "We believe there are also attractive lending opportunities in companies ancillary to and outside of the cannabis industry that could generate attractive risk-adjusted returns."
• "By expanding the investment mandate, we expect to be able to diversify its exposure across industries and credit risk profiles while maintaining deal selectivity."
• "Following the Conversion, we would be able to invest in a much broader universe of assets, including both real estate and non-real estate related assets, as the BDC structure would provide access to a broader range of investment opportunities, including in private and public middle-market companies that may not have sufficient real property collateral coverage to satisfy the REIT regulatory requirements."
• "This expanded mandate is expected to enhance portfolio diversification, increase investment flexibility, and support the pursuit of attractive risk-adjusted returns."
• "We are pursuing the Conversion, which, subject to Board approval, will result in the Company ceasing to operate as a mortgage REIT and electing to be regulated as a BDC under the 1940 Act."
• "We currently expect that the realized tax loss will significantly impact the anticipated distributable earnings for the fourth quarter of 2025, and thus the Company does not anticipate paying a dividend for that quarter."
• "We believe that our cash on hand, capacity available under the Revolving Credit Facility and cash flows from operations will be sufficient to satisfy the operating requirements of our business through at least the next twelve months."
• "We currently do not intend to have leverage of more than one times equity."
• "We expect to employ prudent amounts of leverage and, when appropriate, to use debt as a means of providing additional funds for the acquisition of loans, to refinance existing debt or for general corporate purposes."

Industry Context

The cannabis industry continues to be capital-constrained, lacking access to traditional bank financing due to federal illegality, which the company believes positions it as a prudent financing source. The company's strategic shift from a mortgage REIT to a BDC, coupled with an expanded investment mandate to include ancillary cannabis and non-cannabis industries, reflects an adaptation to evolving market dynamics and a move towards broader diversification beyond its historical niche. This move aims to mitigate risks associated with the highly regulated and federally illegal cannabis sector while capitalizing on wider lending opportunities in the middle-market. Industry consolidation among cannabis operators is also noted, which could further concentrate the company's borrower portfolio.

Comparison to Industry Standards

• The filing does not provide specific comparable companies, projects, or results for global benchmarks to assess the company's performance against industry standards. The focus is on internal financial metrics and strategic shifts.

Corporate Governance

Legal Proceedings

• A complaint was filed on September 9, 2025, in the Superior Court of the State of California in Los Angeles County, naming the company, its manager, and certain officers/directors as defendants.
• An amended complaint was filed on September 19, 2025, by the parent company and two subsidiaries of Private Company G, alleging breach of fiduciary duty, conversion, intentional interference with contract, and unjust enrichment, seeking substantial monetary damages.
• The company has filed separate legal actions in New York against the guarantors of the loan to the two subsidiaries, and those two subsidiaries have filed an action against the company (and others) in New Jersey.
• The company believes the claims are baseless and intends to vigorously defend the matter.
• The company, manager, and affiliated officers/directors are preparing a motion to quash the summonses on grounds of lack of personal jurisdiction in California.

Related Party Transactions

• The company is externally managed by AFC Management, LLC (the Manager), which receives base management fees and incentive compensation.
• Management fees for Q3 2025 were $715,138 (net of $235,670 rebate), and for YTD Sep 2025 were $2,211,686 (net of $624,992 rebate).
• No incentive compensation was incurred for Q3 2025 or YTD Sep 2025, compared to $0.3 million and $5.6 million, respectively, in the prior year periods, due to lower Core Earnings.
• The company reimburses the Manager for certain expenses, including general and administrative expenses ($493,358 for Q3 2025, $1,621,203 for YTD Sep 2025) and professional fees ($21,853 for Q3 2025, $39,985 for YTD Sep 2025).
• Amounts payable to the Manager were approximately $1.4 million as of September 30, 2025.
• The Manager is a wholly-owned subsidiary of Castleground Holdings LLC, with significant beneficial ownership by Leonard Tannenbaum (Chairman), Robyn Tannenbaum (President and CIO), other Tannenbaum family members, Bernard Berman (Investment Committee), Daniel Neville (CEO), Brandon Hetzel (CFO), and Gabriel Katz (Chief Legal Officer.
• The Board approved a new 1940 Act-compliant Investment Advisory Agreement with the Manager, subject to shareholder approval, as part of the BDC conversion. Shareholders approved this on November 6, 2025.
• The company may co-invest with other investment vehicles managed by the Manager or its affiliates. As of September 30, 2025, there were two co-invested loans.
• AFC Agent LLC, an affiliate, serves as administrative and collateral agent for some loans.
• The AFCF Credit Facility, an unsecured revolving credit agreement with AFC Finance, LLC (an affiliate of Leonard M. Tannenbaum), was entered in December 2024 with a $40.0 million commitment and terminated in April 2025.

Stakeholder Impact

• Shareholders experienced a significant net loss and decrease in EPS, leading to a decline in book value per share. Dividends declared per share decreased, and no dividend is anticipated for Q4 2025, impacting income-focused investors. Shareholders approved key proposals for BDC conversion, which could lead to broader investment opportunities and diversification, potentially benefiting long-term value. Shareholders are subject to risks from legal proceedings that could result in substantial monetary damages. There is potential for future equity dilution if new capital raises occur under the $1.0 billion shelf registration.
• Employees (of Manager/Affiliates) saw increased stock-based compensation, indicating continued incentive alignment. The BDC conversion and expanded strategy may create new roles or shift focus for employees involved in investment management.
• Borrowers, including Private Company A, Private Company P, Subsidiary of Private Company G, and Private Company K, are on nonaccrual status, indicating financial distress. Private Company A is in receivership, and Private Company P reached a settlement agreement, which involved a new loan to Private Company T, highlighting active management of distressed loans. The expanded investment strategy could mean new financing opportunities for companies ancillary to cannabis and outside the cannabis industry.
• Creditors (Senior Notes Holders, Revolving Credit Lenders) benefit from the company remaining in compliance with debt covenants for the Revolving Credit Facility and 2027 Senior Notes. The Revolving Credit Facility maturity was extended and commitment increased, providing continued liquidity. The termination of the AFCF Credit Facility (with an affiliate) reduces related-party debt exposure. Increased credit loss provisions and nonaccrual loans indicate higher risk in the loan portfolio, which could impact future repayment capacity if not managed effectively.
• Regulatory Authorities will be involved as the company actively pursues BDC conversion, requiring compliance with 1940 Act regulations. There is ongoing monitoring of cannabis industry regulations due to federal illegality and state law changes.

Next Steps

• The Board will consider other matters required to effect the conversion from a REIT to a BDC in the coming months, following shareholder approval of the Investment Advisory Agreement and reduced asset coverage requirements on November 6, 2025.
• Closing of the settlement agreement with Private Company P and the related new loan to Private Company T is expected to occur in the fourth quarter of 2025.
• AFC Agent continues to monitor the court-appointed receivership for Private Company A to determine principal repayment amounts.
• The company may enter into a new At-the-Market (ATM) program and related sales agreement in the future under its new Shelf Registration Statement.
• The company expects to raise further equity capital and issue debt securities to fund future investments in line with its expanded investment focus.
• The company intends to vigorously defend against the legal complaint filed in California.

Key Dates

Recommendation

The company reported a substantial net loss, a significant increase in credit loss provisions, and a sharp decline in interest income and book value per share. The suspension of the Q4 dividend signals further financial strain. While the strategic shift to a BDC model and expanded investment mandate offer long-term diversification potential, the immediate financial deterioration, coupled with ongoing legal challenges and a high concentration of nonaccrual loans, presents considerable downside risk. Investors should consider selling due to the poor current performance, increased risk profile, and uncertainty surrounding the BDC conversion's full impact and the resolution of legal matters.

Keywords

Cannabis lending, SEC 10-Q, BDC conversion, Advanced Flower Capital, AFCG, Specialty finance, Direct lending, Cannabis industry, Real estate investment trust (REIT), Loan portfolio, Credit losses, Nonaccrual loans, Financial results, Investment strategy, Corporate governance, Shareholder meeting, Dividend policy, Legal proceedings, Risk management